What this trial studies
The MenoScale has been developed from the most common symptoms identified in over 70,000 women to reflect symptom prevalence and user-friendly terminology. It builds and improves on pre-existing scoring tools in four main ways. Firstly, the symptoms assessed are informed by prevalence, as identified from a large cohort. Secondly, the language used to ask about symptoms is modern and accessible as determined through qualitative user research.
Conditions in scope
- Menopause
Interventions
- MenoScale (Other) — Menopause symptom questionnaire
- Greene Climacteric Scale (Other) — Menopause symptom questionnaire
- RAND 36-Item Health Survey 1.0 (Other) — Quality of life questionnaire
- PREDICT-FFQ-v1 (Other) — Food frequency questionnaire
Who can join
Women only · Ages 37 Years to 70 Years
Inclusion criteria
- Female (sex assigned at birth) Aged 37 - 70 years Peri- or postmenopausal (self-reported)
Exclusion criteria
- Currently pregnant and/or lactating History of hysterectomy or oophorectomy History of treatment-induced menopause Body mass index of \< 18.5 Subject is taking \> 5 prescribed medications Subject is unable to provide informed consent online Subject is unable understand the participant information sheet Subject is unable to complete the questionnaires online
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| London | ZOE Ltd | Unknown |
Status & timeline
- Overall status: Completed
- Study type: Observational
- Phase: N/A
- Start date: 2024-11-12
- Primary completion: 2024-12-11
- Last update posted: 2025-01-30
- First posted: 2025-01-30
Sponsor & contact
Lead sponsor: Zoe Global Limited (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- MenoScale validity for menopause symptoms (Baseline)
The ability of the MenoScale to measure the prevalence of menopause-related symptoms in comparison to the most widely-used scale in clinical practice.
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06800560 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.